HistoIndex Secures $9M for US Expansion and AI Pathology Tests

May 02, 2025
HistoIndex has secured a SGD9 million investment led by OCBC to expand its AI-powered digital pathology solutions in the US.
HistoIndex Secures $9M for US Expansion and AI Pathology Tests

HistoIndex has secured a SGD9 million investment to support its expansion in the US, announced in a press release. The funding round was led by OCBC, marking its first investment in a medical technology company, with continued support from existing shareholders ZIG Ventures and SEEDS Capital.

The investment will focus on expanding HistoIndex-partnered laboratories and operations within the US and developing next-generation AI-powered digital pathology tests for Metabolic Dysfunction-Associated Steatohepatitis (MASH) patients. This includes the launch of FibroSIGHT™, a Laboratory Developed Test now available for order in the US, designed to provide accurate liver fibrosis assessments.

Dr. Gideon Ho, CEO of HistoIndex, stated that the investment positions the company for strategic expansion in the US and accelerates the adoption of advanced digital pathology solutions aimed at transforming MASH diagnosis and treatments.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

08/18
Residex.AI Acquires Kevala to Boost AI Workforce Management in Senior Care
08/18
Paradigm Launches AI-Powered Spreadsheet with $5 Million Seed Funding
08/18
Pony.ai Secures Major Investments from Global Firms
08/18
Medallion Secures $43 Million to Launch Credentialing Clearinghouse
08/18
IVIX Secures $60 Million Series B to Combat Financial Crime with AI

More from: Life Sciences

08/18
Residex.AI Acquires Kevala to Boost AI Workforce Management in Senior Care
08/18
MedWellAi Partners with Trump Mobile and BrighterMD for AI-Enhanced Telemedicine Platform
08/16
OpenEvidence AI Scores Perfect 100% on USMLE
08/16
Ryght AI and Biorasi Partner to Enhance Clinical Trial Feasibility
08/15
MIT Researchers Use AI to Design New Antibiotics for Drug-Resistant Bacteria

Subscribe to AI Funding Brief

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like